Related Experiment Video
Updated: Aug 1, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Stabilization and activation of p53 by the coactivator protein TAFII31
T Buschmann1, Y Lin, N Aithmitti
1Derald H. Ruttenberg Cancer Center, Mount Sinai School of Medicine, New York, New York 10029, USA.
Abstract:
Regulation of the stability of p53 is key to its tumor-suppressing activities. mdm2 directly binds to the amino-terminal region of p53 and targets it for degradation through the ubiquitin-proteasome pathway. The coactivator protein TAF(II)31 binds to p53 at the amino-terminal region that is also required for interaction with mdm2. In this report, we demonstrate that expression of TAF(II)31 inhibits mdm2-mediated ubiquitination of p53 and increases p53 levels. TAF(II)31-mediated p53 stabilization results in activation of p53-mediated transcriptional activity and leads to p53-dependent growth arrest in fibroblasts. UV-induced stabilization of p53 coincides with an increase in p53-associated TAF(II)31 and a corresponding decrease in mdm2-p53 interaction. Non-p53 binding mutant of TAF(II)31 fails to stabilize p53. Our results suggest that direct interaction of TAF(II)31 and p53 not only mediates p53 transcriptional activation but also protects p53 from mdm2-mediated degradation, thereby resulting in activation of p53 functions.
Insights
The coactivator TAF(II)31 stabilizes the tumor suppressor p53 by blocking mdm2-mediated degradation. This stabilization activates p53
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- p53 is a crucial tumor suppressor whose stability is tightly regulated.
- MDM2 targets p53 for degradation via the ubiquitin-proteasome pathway.
- The p53 amino-terminal region is critical for both MDM2 interaction and transcriptional regulation.
Purpose of the Study:
- To investigate the role of TAF(II)31 in regulating p53 stability and function.
- To determine if TAF(II)31 can modulate the interaction between p53 and MDM2.
Main Methods:
- Co-immunoprecipitation assays to assess protein interactions.
- Western blotting to measure protein levels (p53, TAF(II)31, MDM2).
- Functional assays measuring p53 transcriptional activity and cell growth arrest.
Main Results:
- TAF(II)31 expression inhibits MDM2-mediated ubiquitination and degradation of p53.
- TAF(II)31 stabilizes p53, leading to enhanced p53 transcriptional activity and p53-dependent growth arrest.
- UV irradiation increases p53-associated TAF(II)31 and decreases MDM2-p53 interaction; a non-binding mutant of TAF(II)31 fails to stabilize p53.
Conclusions:
- Direct interaction of TAF(II)31 with p53 is essential for p53 stabilization.
- TAF(II)31 protects p53 from MDM2-mediated degradation, thereby activating p53's tumor-suppressive functions.
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
DNA Damage Can Stall the Cell Cycle
PI3K/mTOR/AKT Signaling Pathway

